chr16-89686735-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_052988.5(CDK10):āc.25G>Cā(p.Glu9Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000416 in 1,611,248 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_052988.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CDK10 | NM_052988.5 | c.25G>C | p.Glu9Gln | missense_variant | 1/13 | ENST00000353379.12 | |
LINC02166 | NR_184150.1 | n.178C>G | non_coding_transcript_exon_variant | 1/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CDK10 | ENST00000353379.12 | c.25G>C | p.Glu9Gln | missense_variant | 1/13 | 1 | NM_052988.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152222Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000579 AC: 14AN: 241752Hom.: 0 AF XY: 0.0000606 AC XY: 8AN XY: 131922
GnomAD4 exome AF: 0.0000418 AC: 61AN: 1458908Hom.: 0 Cov.: 31 AF XY: 0.0000427 AC XY: 31AN XY: 725606
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152340Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74480
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 17, 2024 | The c.25G>C (p.E9Q) alteration is located in exon 1 (coding exon 1) of the CDK10 gene. This alteration results from a G to C substitution at nucleotide position 25, causing the glutamic acid (E) at amino acid position 9 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Al Kaissi syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory of Medical Genetics (UMR_S 1112), INSERM/Strasbourg University | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at